Neumann S, Krause G, Chey S, Paschke R
Third Medical Department, University of Leipzig, D-04103 Leipzig, Germany.
Mol Endocrinol. 2001 Aug;15(8):1294-305. doi: 10.1210/mend.15.8.0672.
A specific H-bonding network formed between the central regions of transmembrane domain 6 and transmembrane domain 7 has been proposed to be critical for stabilizing the inactive state of glycoprotein hormone receptors. Many different constitutively activating TSH receptor point mutations have been identified in hyperfunctioning thyroid adenomas in the lower portion of transmembrane domain 6. Position D633 in transmembrane domain 6 of the human TSH receptor is the only one in which four different constitutively activating amino acid exchanges have been identified. Further in vitro substitutions led to constitutive activation of the TSH receptor (D633Y, F, C) as well as to the first inactivating TSH receptor mutation in transmembrane domain 6 without changes of membrane expression or TSH binding (D633R). Molecular modeling of this inactivating TSH receptor mutation revealed potential interaction partners of R633 in transmembrane domain 3 and/or transmembrane domain 7, presumably via hydrogen bonds that could be responsible for locking the TSH receptor in a completely inactive state. To further elucidate the H-bond network that most likely maintains the inactive state of the TSH receptor, we investigated these potential interactions by generating TSH receptor double mutants designed to break up possible H bonds. We excluded S508 in transmembrane domain 3 as a possible interaction partner of R633. In contrast, a partial response to TSH stimulation was rescued in a receptor construct with the double-substitution D633R/N674D. Our results therefore confirm the H bond between position 633 in transmembrane domain 6 and 674 in transmembrane domain 7 suggested by molecular modeling of the inactivating mutation D633R. Moreover, the mutagenesis results, together with a three-dimensional structure model, indicate that for TSH receptor activation and G protein-coupled signaling, at least one free available carboxylate oxygen is required as a hydrogen acceptor atom at position 674 in transmembrane domain 7.
有人提出,跨膜结构域6和跨膜结构域7的中心区域之间形成的特定氢键网络对于稳定糖蛋白激素受体的非活性状态至关重要。在跨膜结构域6下部的高功能甲状腺腺瘤中,已鉴定出许多不同的组成型激活促甲状腺激素(TSH)受体点突变。人TSH受体跨膜结构域6中的D633位点是唯一已鉴定出四种不同组成型激活氨基酸交换的位点。进一步的体外替代导致TSH受体的组成型激活(D633Y、F、C),以及跨膜结构域6中第一个失活的TSH受体突变,而膜表达或TSH结合没有变化(D633R)。这种失活的TSH受体突变的分子模型揭示了跨膜结构域3和/或跨膜结构域7中R633的潜在相互作用伙伴,推测是通过氢键,这可能负责将TSH受体锁定在完全非活性状态。为了进一步阐明最有可能维持TSH受体非活性状态的氢键网络,我们通过生成旨在破坏可能氢键的TSH受体双突变体来研究这些潜在相互作用。我们排除了跨膜结构域3中的S508作为R633的可能相互作用伙伴。相反,在具有双替代D633R/N674D的受体构建体中,对TSH刺激的部分反应得以恢复。因此,我们的结果证实了失活突变D633R的分子模型所暗示的跨膜结构域6中的633位与跨膜结构域7中的674位之间的氢键。此外,诱变结果与三维结构模型一起表明,对于TSH受体激活和G蛋白偶联信号传导,跨膜结构域7中的674位至少需要一个游离的可利用羧酸盐氧作为氢受体原子。